Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

Risankizumab for the Treatment of the Patients with Moderate to Severe Plaque Psoriasis During a 24-Week Period: Real-Life Experience

Total article views   HTML views PDF downloads Totals
1,584 Dovepress* 1,472+ 39 1,511
PubMed Central* 112 49 161
Totals 1,584 88 1,672
*Since 20 December 2023

View citations on PubMed Central and Google Scholar